Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Delivering purposeful solutions at Obesity Week 2025

    October 9, 2025 | Obesity Week 

    We’re attending Obesity Week 2025, the world’s leading event dedicated to obesity research and care, to showcase how our integrated expertise is advancing progress in obesity and cardiometabolic health.

    - PMLiVE

    Obesity Week 2025 is the premier global event dedicated to obesity research, prevention, and care – bringing together leading scientists, clinicians, and innovators to advance progress in one of the most dynamic areas of healthcare.​

    At Inizio, we’re uniting science, strategy, and creativity to deliver purposeful solutions across obesity and cardiometabolic health. Our integrated teams collaborate across the full commercialization journey to help clients navigate complexity, unlock value, and enhance outcomes at every stage of development and delivery.​

    Our experience spans the full obesity ecosystem: we’ve supported over 20 leading anti-obesity therapies, partnered on 80% of the largest GLP-1 assets, and worked across 18 specialized services to deliver smarter, connected solutions that make an impact.​

    Visit us at booth #812 to meet our experts and explore how Inizio’s integrated expertise is transforming the future of obesity and cardiometabolic care.​

    If you’d like to meet with us at Obesity Week, please get in touch.

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    EphMRA Annual Conference 2017

    Visit us on stand number 14

    Richard Head nominated for EphMRA Award

    We are delighted to announce that Research Partnership’s Director Richard Head has been nominated for The EphMRA President’s Award for Contribution to Pharmaceutical Market Research.According to EphMRA, Richard has been...

    Research Partnership launches new patient Living With Non-alcoholic Steatohepatitis (NASH) report

    Living with Non-alcoholic Steatohepatitis (NASH) is a study conducted amongst 100 adults with NASH in the US. The study employs a mixed quantitative/qualitative methodology and will be available to purchase...

    EULAR Annual European Congress of Rheumatology 2017

    Join us at EULAR Congress 2017 in Madrid, 14-17 June

    PEGASUS UNVEILS NEW BRAND IDENTITY AS IT CELEBRATES A YEAR AS PART OF ASHFIELD

    Pegasus, an Ashfield company, part of UDG Healthcare plc, has unveiled a new brand identity signaling its successful integration with the global business, a year on from acquisition. Conceived by...

    20 questions: Round 2

    As it's our 20th year anniversary, we invited our employees to play our version of 20 questions - this month "What do you love about your job?"Watch the video: http://bit.ly/2qA1oP9

    Taking an integrated approach to research

    Director Melinda Shorr and Associate Director Steven Helm discuss the benefits of integrated research techniques.Watch the video: http://bit.ly/2qF0qO2

    Online Community Research

    What to consider when running an online research community?

    Research Partnership appoints Helen Parfitt as Director, Head of Therapy Watch

    Helen Parfitt has joined Research Partnership as Head of Therapy Watch at the company’s global head office in London. Therapy Watch is a ‘real-time’ syndicated global market tracking tool that...

    Research Partnership is expanding its US capabilities with new offices opening in San Francisco and New York

    Research Partnership is today expanding its US operations across both the West and East Coast. Director Tom Winter has relocated from London and is today opening a new office in...